Patent Application: Method for Acute Respiratory Distress Syndrome Treatment
Summary
The USPTO has published a new patent application (US20260085098A1) from Revolo Biotherapeutics Limited for a method to treat acute respiratory distress syndrome. The application details a treatment method involving the administration of a specific peptide molecule during or in response to a relapse to induce remission.
What changed
This document is a publication of a patent application filed by Revolo Biotherapeutics Limited, identified as US20260085098A1. The application describes a method for the acute treatment of acute respiratory distress syndrome (ARDS) by administering a specific peptide molecule during a relapse to induce remission. The filing date was May 13, 2025, and the publication date is March 26, 2026.
As this is a patent application, it does not impose direct regulatory obligations or compliance deadlines on entities. However, it signifies potential future intellectual property rights and may influence research and development in ARDS treatments. Companies operating in the pharmaceutical and biotechnology sectors, particularly those involved in peptide therapeutics or ARDS treatment, should be aware of this filing for competitive intelligence and potential licensing or collaboration opportunities.
Archived snapshot
Mar 26, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
METHOD FOR THE TREATMENT OF AN ACUTE RESPIRATORY DISTRESS SYNDROME
Application US20260085098A1 Kind: A1 Mar 26, 2026
Assignee
Revolo Biotherapeutics Limited
Inventors
Andrew Lightfoot, Nicola Cooper, Donata Federici Canova, Roly Foulkes
Abstract
The present invention relates to a method for the acute treatment of a relapsing-remitting condition, the method comprising the step of administering to a subject in need thereof one or more doses of an effective amount of a peptide molecule as defined in claim 1 in response to or during a relapse, wherein the method causes remission of the condition.
CPC Classifications
C07K 14/35 A61K 45/06 A61K 38/00
Filing Date
2025-05-13
Application No.
19207227
Named provisions
Related changes
Get daily alerts for USPTO Patent Applications - Peptides (C07K)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Applications - Peptides (C07K) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.